Relationship between Maximum Tongue Pressure Value and Age, Occlusal Status, or Body Mass Index among the Community-Dwelling Elderly

por Suzuki, Hiroki, Ayukawa, Yasunori, Ueno, Yoko, Atsuta, Ikiru, Jinnouchi, Akio, Koyano, Kiyoshi
Publicado 2020

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD(+) acute myeloid leukemia

por Ueno, Yoko, Mori, Masamichi, Kamiyama, Yoshiteru, Saito, Rika, Kaneko, Naoki, Isshiki, Eriko, Kuromitsu, Sadao, Takeuchi, Masahiro
Publicado 2019

Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma

por Shitara, Kohei, Kawazoe, Akihito, Hirakawa, Akihiro, Nakanishi, Yuka, Furuki, Satomi, Fukuda, Musashi, Ueno, Yoko, Raizer, Jeffrey, Arozullah, Ahsan
Publicado 2022

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

por Mori, Masamichi, Kaneko, Naoki, Ueno, Yoko, Yamada, Masaki, Tanaka, Ruriko, Saito, Rika, Shimada, Itsuro, Mori, Kenichi, Kuromitsu, Sadao
Publicado 2017

Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells

por Kawase, Tatsuya, Nakazawa, Taisuke, Eguchi, Tomohiro, Tsuzuki, Hirofumi, Ueno, Yoko, Amano, Yasushi, Suzuki, Tomoyuki, Mori, Masamichi, Yoshida, Taku
Publicado 2019